September 14, 2022 Self-correction to the draft resolution of the General Meeting of Ryvu Therapeutics S.A. convened for September 19, 2022
Read More
August 19, 2022 Convening of the Extraordinary General Shareholders Meeting of Ryvu Therapeutics S.A.
Read More
August 19, 2022 Ryvu Therapeutics’ development plans for 2022-2024
Read More
August 18, 2022 Change of the date of publication of the periodic report for the first half of 2022
Read More
August 17, 2022 Conclusion of a financing agreement with the European Investment Bank
Read More
July 26, 2022 Changes in Ryvu’s Management Board
Read More
July 8, 2022 Information on a potential supply of shares in connection with the expiration of the lock-up period for shares under the Stock Grant Program
Read More
July 7, 2022 Execution of an exclusive license agreement with Exelixis, Inc. to develop novel STING agonist-based targeted cancer therapies
Read More
July 1, 2022 Shareholders controlling at least 5% of the votes at the General Shareholders Meeting of Ryvu Therapeutics S.A. convened on June 30, 2022
Read More
July 1, 2022 Resolutions adopted by the General Shareholders Meeting of Ryvu Therapeutics S.A.
Read More
June 10, 2022 Publication of the updated phase 1b clinical and preclinical data for RVU120 and phase 1/2 SEL24 (MEN1703)
Read More
June 3, 2022 Convening the Ordinary General Shareholders Meeting of Ryvu Therapeutics S.A.
Read More
May 18, 2022 Ryvu Therapeutics S.A. Q1 2022 Financial Report
Read More
May 12, 2022 New data from RVU120 and SEL24(MEN1703) programs to be presented at the EHA Hybrid Congress 2022
Read More
April 27, 2022 Ryvu Therapeutics to present recent RVU120 and SEL24 (MEN1703) data at ASCO 2022 Annual Meeting
Read More
April 1, 2022 Notification from person discharging managerial responsibilities in the Company due to execution of the Stock Grant Program – Article 19 of MAR
Read More
March 8, 2022 Ryvu Therapeutics to present recent data from oncology programs at AACR 2022 Annual Meeting
Read More
January 19, 2022 Publication dates for periodic reports in 2022
Read More
January 19, 2022 Delivery of a lawsuit for payment in connection with the construction of the Research and Development Center
Read More
Posts navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok Privacy policy